Zonisamide 100Mg Cap
PINIHL-AET
Phase 2 small_molecule terminated
Quick answer
Zonisamide 100Mg Cap for Hearing Loss, Noise-Induced is a Phase 2 program (small_molecule) at UNITED THERAPEUTICS Corp with 2 ClinicalTrials.gov record(s).
Program details
- Company
- UNITED THERAPEUTICS Corp
- Indication
- Hearing Loss, Noise-Induced
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- terminated